Securing sustainable funding for viral hepatitis elimination plans

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries

(2018) A. M. Falla et al.   BMC INFECTIOUS DISEASES

Assessing the cost-effectiveness of hepatitis C screening strategies in France

(2018) Sylvie Deuffic-Burban et al.   JOURNAL OF HEPATOLOGY

Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies

(2018) Laura Pimpin et al.   JOURNAL OF HEPATOLOGY

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

(2018) Kelly Safreed-Harmon et al.   SEMINARS IN LIVER DISEASE

Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017

(2018) Jeffrey V Lazarus et al.   Journal of the International AIDS Society

The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease

(2018) Zobair Younossi et al.   JOURNAL OF VIRAL HEPATITIS

Micro-elimination – A path to global elimination of hepatitis C

(2017) Jeffrey V. Lazarus et al.   JOURNAL OF HEPATOLOGY

The International Finance Facility for Immunisation: stakeholders’ perspectives

(2016) Tim Crocker-Buque et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights

(2016) Natasha K. Martin et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals

(2016) Jagpreet Chhatwal et al.   HEPATOLOGY

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences

(2016) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs

(2015) Anthony Cousien et al.   HEPATOLOGY

The Undiagnosed Chronically-Infected HCV Population in France. Implications for Expanded Testing Recommendations in 2014

(2015) Cécile Brouard et al.   PLoS One

Strategies for the treatment of Hepatitis C in an era of interferon-free therapies: what public health outcomes do we value most?

(2014) Hamish Innes et al.   GUT

Chronic hepatitis C virus (HCV) disease burden and cost in the United States

(2012) Homie Razavi et al.   HEPATOLOGY